Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
Konya City Hospital
68 participants
Jul 1, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.
Eligibility
Inclusion Criteria2
- Infants of families who agree to participate in the study
- Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis.
Exclusion Criteria3
- Infants whose families did not provide consent
- Infants with a syndromic appearance or congenital heart disease
- Preterm infants born after 32 weeks of gestation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intubating the infant, administering intratracheal surfactant, and then extubating them back to nasal respiratory support (ENSURE method)
Delivering surfactant via a thin catheter (5F) directly into the trachea while the infant remains on existing nasal respiratory support, without disconnecting them from it (LISA method)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06880016